|
|
||||||||
Gastrointestinal Imaging |
1 From the Departments of Radiology (M.S.P., R.L.B., J.H.O., S.R.C., L.E.H.) and Surgery (J.W.M.), University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA 15213-2582. From the 1996 RSNA scientific assembly. Received January 28, 2000; revision requested March 15; revision received May 5; accepted May 22. Address correspondence to M.S.P. (e-mail: petersonms@radserv.arad.upmc.edu).
PURPOSE: To determine the prevalence of clinically unsuspected hepatocellular carcinoma (HCC) with advanced cirrhosis and assess the sensitivity of helical computed tomographic (CT) surveillance for tumor detection in these patients.
MATERIALS AND METHODS: Prospective direct correlation of CT findings with explanted liver specimen findings was performed in 430 transplant recipients with cirrhosis. The prevalence of clinically unsuspected HCC according to liver disease cause was evaluated. Serum
-fetoprotein (AFP) values in patients with and those without tumor were recorded. Prospective and retrospective CT tumor detection was evaluated with respect to CT technique and time from CT to transplantation.
RESULTS: HCC was found in 59 (14%) of 430 transplant recipients without suspicion of tumor before referral for transplantation. HCC was most prevalent with hepatitis B (27%) and hepatitis C (22%). Serum AFP values were not sensitive for detection of most small tumors. With triphasic helical CT, the prospective and retrospective rates of identifying patients with tumor were 59% and 68%, respectively; the prospective and retrospective tumor nodule detection rates were 37% and 44%, respectively. Tumor detection rates were highest with CT performed within 67 days before transplantation.
CONCLUSION: Clinically unsuspected HCC is most prevalent with cirrhosis secondary to hepatitis B or C, and, when evaluated at CT, is best detected with triphasic contrast materialenhanced helical imaging performed within 67 days before transplantation.
Index terms: Liver, cirrhosis, 761.288, 761.794 Liver, CT, 761.12111, 761.12112, 761.12114, 761.12115 Liver, transplantation, 761.459 Liver neoplasms, 761.323 Liver neoplasms, CT, 761.12111, 761.12112, 761.12114, 761.12115
This article has been cited by other articles:
![]() |
X. Ma, A. E. Samir, N.-S. Holalkere, and D. V. Sahani Optimal Arterial Phase Imaging for Detection of Hypervascular Hepatocellular Carcinoma Determined by Continuous Image Capture on 16-MDCT Am. J. Roentgenol., September 1, 2008; 191(3): 772 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Chung, J. S. Yu, J. H. Kim, M.-J. Kim, and K. W. Kim Nonhypervascular Hypoattenuating Nodules Depicted on Either Portal or Equilibrium Phase Multiphasic CT Images in the Cirrhotic Liver Am. J. Roentgenol., July 1, 2008; 191(1): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Meyer, B. B. Frericks, M. Voges, M. Borchert, P. Martus, J. Justiz, K.-J. Wolf, and F. K. Wacker Visualization of Hypervascular Liver Lesions During TACE: Comparison of Angiographic C-Arm CT and MDCT Am. J. Roentgenol., April 1, 2008; 190(4): W263 - W269. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ronzoni, D. Artioli, R. Scardina, L. Battistig, E. Minola, S. Sironi, and A. Vanzulli Role of MDCT in the Diagnosis of Hepatocellular Carcinoma in Patients with Cirrhosis Undergoing Orthotopic Liver Transplantation Am. J. Roentgenol., October 1, 2007; 189(4): 792 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Brillet, V. Paradis, G. Brancatelli, A.-S. Rangheard, Y. Consigny, A. Plessier, F. Durand, J. Belghiti, D. Sommacale, and V. Vilgrain Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S296 - S305. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Kim, C. S. Kim, G. H. Chung, Y.-M. Han, S. Y. Lee, S. B. Chon, and J. M. Lee Comparison of Gadobenate Dimeglumine-Enhanced Dynamic MRI and 16-MDCT for the Detection of Hepatocellular Carcinoma Am. J. Roentgenol., January 1, 2006; 186(1): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, M. J. Kim, H. K. Lim, and S. J. Lee Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma Am. J. Roentgenol., April 1, 2005; 184(4): 1069 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Pandharipande, G. A. Krinsky, H. Rusinek, and V. S. Lee Perfusion Imaging of the Liver: Current Challenges and Future Goals Radiology, March 1, 2005; 234(3): 661 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Iannaccone, A. Laghi, C. Catalano, P. Rossi, F. Mangiapane, T. Murakami, M. Hori, F. Piacentini, I. Nofroni, and R. Passariello Hepatocellular Carcinoma: Role of Unenhanced and Delayed Phase Multi-Detector Row Helical CT in Patients with Cirrhosis Radiology, February 1, 2005; 234(2): 460 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Steingruber, A. Mallouhi, B. V. Czermak, P. Waldenberger, E. Gassner, F. Offner, A. Chemelli, A. Koenigsrainer, W. Vogel, and W. R. Jaschke Pretransplantation Evaluation of the Cirrhotic Liver with Explantation Correlation: Accuracy of CT Arterioportography and Digital Subtraction Hepatic Angiography in Revealing Hepatocellular Carcinoma Am. J. Roentgenol., July 1, 2003; 181(1): 99 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, S. Bent, and J. Kohlwes Test Characteristics of {alpha}-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis Ann Intern Med, July 1, 2003; 139(1): 46 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Carlos, H. M. Kim, H. K. Hussain, I. R. Francis, H. V. Nghiem, and A. M. Fendrick Developing a Prediction Rule to Assess Hepatic Malignancy in Patients with Cirrhosis Am. J. Roentgenol., April 1, 2003; 180(4): 893 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brancatelli, R. L. Baron, M. S. Peterson, and W. Marsh Helical CT Screening for Hepatocellular Carcinoma in Patients with Cirrhosis: Frequency and Causes of False-Positive Interpretation Am. J. Roentgenol., April 1, 2003; 180(4): 1007 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bhartia, J. Ward, J. A. Guthrie, and P. J. Robinson Hepatocellular Carcinoma in Cirrhotic Livers: Double-Contrast Thin-Section MR Imaging with Pathologic Correlation of Explanted Tissue Am. J. Roentgenol., March 1, 2003; 180(3): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Teefey, C. C. Hildeboldt, F. Dehdashti, B. A. Siegel, M. G. Peters, J. P. Heiken, J. J. Brown, E. G. McFarland, W. D. Middleton, D. M. Balfe, et al. Detection of Primary Hepatic Malignancy in Liver Transplant Candidates: Prospective Comparison of CT, MR Imaging, US, and PET Radiology, February 1, 2003; 226(2): 533 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Baker Abdominal CT Screening: Inflated Promises, Serious Concerns Am. J. Roentgenol., January 1, 2003; 180(1): 27 - 30. [Full Text] [PDF] |
||||
![]() |
B. K. Kang, J. H. Lim, S. H. Kim, D. Choi, H. K. Lim, W. J. Lee, and S. J. Lee Preoperative Depiction of Hepatocellular Carcinoma: Ferumoxides-enhanced MR Imaging versus Triple-Phase Helical CT Radiology, January 1, 2003; 226(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mori, J. Scheidler, T. Helmberger, N. Holzknecht, R. Schauer, C. A. Schirren, I. Bittmann, M. Dugas, and M. Reiser Detection of Malignant Hepatic Lesions Before Orthotopic Liver Transplantation: Accuracy of Ferumoxides-Enhanced MR Imaging Am. J. Roentgenol., October 1, 2002; 179(4): 1045 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Bennett, G. A. Krinsky, R. J. Abitbol, S. Y. Kim, N. D. Theise, and L. W. Teperman Sonographic Detection of Hepatocellular Carcinoma and Dysplastic Nodules in Cirrhosis: Correlation of Pretransplantation Sonography and Liver Explant Pathology in 200 Patients Am. J. Roentgenol., July 1, 2002; 179(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brancatelli, M. P. Federle, L. Grazioli, R. Golfieri, and R. Lencioni Large Regenerative Nodules in Budd-Chiari Syndrome and Other Vascular Disorders of the Liver: CT and MR Imaging Findings with Clinicopathologic Correlation Am. J. Roentgenol., April 1, 2002; 178(4): 877 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Baron and M. S. Peterson From the RSNA Refresher Courses: Screening the Cirrhotic Liver for Hepatocellular Carcinoma with CT and MR Imaging: Opportunities and Pitfalls RadioGraphics, October 1, 2001; 21(90001): S117 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brancatelli, M. P. Federle, L. Grazioli, and B. I. Carr Hepatocellular Carcinoma in Noncirrhotic Liver: CT, Clinical, and Pathologic Findings in 39 U.S. Residents Radiology, January 1, 2002; 222(1): 89 - 94. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |